699 results on '"Merelli, Ivan"'
Search Results
2. Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice
3. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID
4. CD32 captures committed haemogenic endothelial cells during human embryonic development
5. Durable and efficient gene silencing in vivo by hit-and-run epigenome editing
6. Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cells
7. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease
8. Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential
9. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
10. Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis
11. Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells
12. StreamFlow: cross-breeding cloud with HPC
13. A novel gene signature to diagnose MASLD in metabolically unhealthy obese individuals
14. In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases
15. Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
16. GenHap: A Novel Computational Method Based on Genetic Algorithms for Haplotype Assembly
17. Interferon‐inducible phospholipids govern IFITM3‐dependent endosomal antiviral immunity
18. NeoHiC: A Web Application for the Analysis of Hi-C Data
19. Identification of a retinoic acid-dependent haemogenic endothelial progenitor from human pluripotent stem cells
20. Combining Bayesian Approaches and Evolutionary Techniques for the Inference of Breast Cancer Networks
21. AAV vectors trigger DNA damage responses and STING-dependent inflammation in human CNS cells
22. Supplementary Table 10 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
23. FIGURE 1 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
24. Supplementary Figure S4 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
25. FIGURE 3 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
26. FIGURE 5 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
27. Supplementary Table 9 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
28. FIGURE 2 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
29. Supplementary Table 7 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
30. Supplementary Table 3 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
31. Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
32. Supplementary Table 8 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
33. Supplementary Table 5 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
34. Supplementary Table 2 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
35. Supplementary Table 4 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
36. FIGURE 4 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
37. Data from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
38. Supplementary Table 6 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
39. Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD
40. BAR-Seq clonal tracking of gene-edited cells
41. Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency
42. Comparing Deep and Machine Learning Approaches in Bioinformatics: A miRNA-Target Prediction Case Study
43. High Performance Computing for Haplotyping: Models and Platforms
44. TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells
45. Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency
46. Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis
47. Exploiting Docker containers over Grid computing for a comprehensive study of chromatin conformation in different cell types
48. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
49. Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses
50. NeoHiC: A Web Application for the Analysis of Hi-C Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.